本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vitro Biopharma

成交量:- -
成交额:- -
市值:- -
市盈率:- -
高:- -
开:- -
低:- -
收:- -
52周最高:- -
52周最低:- -
股本:451.77万
流通股本:181.82万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9380
净资产收益率:-614.04%
总资产收益率:-59.74%
市净率:0.00
市盈率(LYR):- -

数据加载中...

2026/03/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/09/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/06/20

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/20

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/01/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/09/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/09/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/30

SEC问询函

Form CORRESP - Correspondence
2024/08/24

SEC问询函

Form CORRESP - Correspondence
2024/08/23

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/09

SEC问询函

Form CORRESP - Correspondence
2024/08/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/02

SEC问询函

Form CORRESP - Correspondence
2024/07/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]